Infinity Pharmaceuticals, Inc.
INFIDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001113148
Infinity Pharmaceuticals, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Infinity Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −10 vs. Q3 2021
- Shares held
- 41.7M
- −5.22M (−11.1%) vs. Q3 2021
- Total value
- $93.8M
- −$66.7M (−41.5%) vs. Q3 2021
- New holders
- 9
- 30 more added
- Sold out
- 19
- 32 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INFI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 3 | $15 |
| Q3 2023 | 3 | $2.90K |
| Q2 2023 | 45 | $4.23M |
| Q1 2023 | 53 | $3.10M |
| Q4 2022 | 68 | $13.9M |
| Q3 2022 | 76 | $36.8M |
| Q2 2022 | 78 | $19.0M |
| Q1 2022 | 93 | $44.3M |
| Q4 2021 | 97 | $93.8M |
| Q3 2021 | 107 | $160.5M |
| Q2 2021 | 97 | $130.9M |
| Q1 2021 | 83 | $135.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Infinity Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −89,878−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −70,431−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −57,400−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −47,006−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −45,150−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −33,123−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −25,060−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −21,609−100.0% | Sold out |
| B. Riley Wealth Management, Inc. | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,428−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −501−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −164−100.0% | Sold out |
| Cahill Financial Advisors Inc | 0 | $0 | 0.00% | −115−100.0% | Sold out |